glp-1 treatment How to use receptor agonist therapy safely and effectively Struggling with GLP-1 therapy side

Kelly, E

"These drugs have the potential to bring about substantial weight loss, particularly in the first year," says Juan Franco, co-lead researcher from Heinrich Heine University Dsseldorf, Germany

Some novel GLP-1 RAs, such as PT302 and PT320, have data to show that they may reduce levodopa-induced dyskinesia and dopaminergic degeneration, suggesting a potential for synergistic therapy with levodopa

Ozempic, for example, is approved by the FDA to reduce the risk of cardiovascular problems in people with type 2 diabetes and heart disease, while Zepbound is approved to treat obstructive sleep apnea

These services combine medication management with behavioral support, creating comprehensive approaches to weight and metabolic health

And I think thats why everyone on the team needs to be thinking about this as a part of the puzzle, because these medications are very popular and widespread use